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be used systematically.” Conclusions regarding the value of revas-
cularization can clearly not be deduced from a study of only
revascularized patients, especially if one considers the high re-
ported rate of recurrent ventricular arrhythmias despite routine
revascularization (i.e., 32/62 5 58%). Great caution must be
exerted in interpreting the reported data to avoid unfounded
conclusions and their important implications.
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REPLY
We appreciate Dr. Khairy’s interest in our article recently pub-
lished in the Journal of the American College of Cardiology.
Dr. Khairy argues that some methodologic aspects of the work
are questionable. The objective of our study was not to investigate
independent factors predictive of recurrent events during follow-
up, but rather to compare several variables between those having or
not having recurrent events. In that case, and owing to the limited
number of patients, a univariate analysis seems correct.
Our report is an observational study in a very specific patient
population with limited information on the literature so far. We
never intended to investigate the value of revascularization or
antiarrhythmic therapy in such a population. The objective was to
report that the combined approach gives excellent results in terms
of survival (compared to historical series), and that revasculariza-
tion alone does not prevent arrhythmic recurrences.
The conclusion that an individualized combined approach gives
excellent results and should be used systematically seems reason-
able. In patients with a clear indication for revascularization and
who have suffered clinically sustained ventricular arrhythmias, a
randomized study using different combinations of revascularization
yes or no and antiarrhythmic therapy yes or no would probably be
methodologically correct but certainly ethically incorrect.
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Management of Anomalous Coronary Artery
The Davis et al. (1) finding of a 0.17% prevalence of anomalous
coronary artery from the wrong aortic sinus in an asymptomatic
pediatric population is important data. These investigators and
others (2) suggest that surgical management is mandatory, while
admitting that the duration of coronary artery bypass graft surgery
(CABG) patency is not known. The accompanying editorial is
more cautious for asymptomatic patients ,35 years of age, citing
uncertainty surrounding the most appropriate management option
and stating that “surgical repair should be considered” (3). Pelliccia
(3) also believes that these lesions in patients .35 years of age have
“likely no clinical significance” and “most probably [need] no
surgical treatment.”
I am concerned that the specter of sudden death seems to have
compelled many to “do something,” in the absence of good
outcomes data. A prevalence of ;0.1% to 0.2% among ;4 million
live births annually in the U.S. (4) yields about 4,000 to 8,000
children born each year with these coronary anomalies. Of 275
million people in the U.S. (assuming a low incidence of death),
;275,000 to 550,000 would be affected; approximately half are
under age 35. (As an aside, the risk in an adult over age 35 may not
be insignificant, as a recent case report shows [5].) And yet, the
number of cases of sudden death appears exceedingly small when
compared with these population figures (,,1%), as data from U.S.
and Italian registries suggest (2). Is this truly the natural history of
these lesions, or are we underestimating the risk?
The CABG procedure is not risk-free (6,7). Admittedly, surgi-
cal risk is likely to be lower in patients with anomalous coronary
artery from the wrong sinus than with other coronary problems, as
patients are typically healthy. Nevertheless, even the simplest of
pediatric heart operations carry risks of neurologic, myocardial, and
other organ injury, as well as death. Moreover, surgical “repair” by
no means guarantees cure. One recent study of children showed
patency rates of 78% and 36% for internal mammary grafts and
saphenous vein grafts, respectively, at 10 years (7). Such figures
virtually guarantee reoperation in most patients, with its concom-
itant risks.
Some physicians and families may prefer to accept the surgical
risks rather than to live with an unknown potential for sudden
death, but these risks must be fully understood before an operation
is undertaken. I do believe that activity can often be modified, and
therefore risk can be reduced, even if not eliminated. But the
unanswered questions remain: 1) What is the true natural history
of these coronary anomalies? 2) What is the long-term “unnatural
history” of CABG in children? Although sudden death, particu-
larly in a young and seemingly healthy person, is especially tragic,
we must remember the fundamental principle of primum non
nocere—“first, do no harm.” Therefore, when it comes to surgical
management, one must consider the adage, however difficult:
“Don’t just do something, stand there!”
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Major Coronary Artery
Anomalies in the Pediatric Population
We read with interest the article by Davis et al. (1). The
investigators nicely address the problems related to the identifica-
tion and treatment of these rare coronary anomalies. Although
agreeing with the indications for intervention, we believe that
aortocoronary bypass grafting may not be the optimal treatment.
The long-term patency of arterial grafts (78% at 10 years for
internal thoracic artery grafts in the treatment of young patients
after Kawasaki disease) (2) may not be satisfactory for children. In
addition, given that most of the time the flow through the affected
coronary is unimpeded, the graft sets up a competitive flow, which
might jeopardize long-term patency. We have taken a different
approach, adapted from the translocation of intramural coronary
arteries during the arterial switch operation for transposition of the
great arteries. The inner wall of the sinus of Valsalva along the
intramural portion of the artery is excised to enlarge the ostium.
An autologous pericardial patch is used to enlarge the proximal
portion of the artery on its external aspect. This is readily
accomplished by transection of the aorta and pulmonary artery to
obtain a good exposure. This strategy eliminates the acute takeoff
angle and external compression of the anomalous coronary, while
avoiding competitive flow through a graft, and thus may result in
better long-term patency than aortocoronary bypass. We offer this
as an alternative to the use of aortocoronary bypass or internal
thoracic artery grafting.
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REPLY
The letters from Drs. Davidson and Karl and Dr. Phoon highlight
the controversy and difficulties inherent in planning intervention
for anomalous origin of the coronary arteries (AOCA). The
principal goal of our study was to estimate the prevalence of these
anomalies in a relatively normal and asymptomatic population (1).
This represents only the first step in defining a disease process.
Phoon correctly states that the true natural history of these
coronary artery anomalies is unknown. The sporadic nature of
AOCA causes difficulties in determining the natural history of
these abnormalities when they present as an incidental finding.
Conceivably, a national or international registry for such patients
could be established with the goal of defining both the natural and
surgical history of these patients.
We concur with the management outline described in the
editorial comment by Pellicia (2). Certainly, surgical intervention
is mandatory in any young patient with symptoms; or those with
AOCA as an incidental finding and signs of myocardial perfusion
abnormalities identified after rigorous laboratory examination.
Pellicia states that uncertainty exists regarding patients without
symptoms or signs of myocardial ischemia. Therefore, it seems
reasonable that these patients are not exposed to risk for sudden
death, and surgical management should be considered. One can
take issue with Phoon’s statement that “activity can be modified,
and therefore risk can be reduced.” Behavioral modification might
be possible, but at what price? Our patients and their families are
routinely provided the option of reduced physical activity as an
alternative to operative intervention. In this population of other-
wise healthy young persons, lifestyle considerations tend to direct
the families to choose surgical treatment.
The surgical approach depends on the specific anatomy and
circumstances. Davidson and Karl suggest that aortocoronary
bypass grafting may not be the optimal procedure for AOCA. We
agree that arterioplasty involving the ostium is appropriate and
perhaps preferable, when the right coronary artery with anomalous
origin (ARCA) follows an intramural course. We have performed
this operation in two patients with good immediate results. In two
other patients, the ARCA did not demonstrate an intramural
course, and bypass seemed preferable. We have operated on three
patients with left coronary arteries arising from the right sinus, all
without intramural component and all were bypassed. All of these
grafts have remained patent up to three years postoperatively.
Furthermore, two of the three grafts were performed without
cardiopulmonary bypass, thus avoiding possible neurological com-
plications. The long-term results including graft patency duration
for these surgical procedures remain unknown. Extrapolation of
data regarding Kawasaki disease patients to AOCA patients may
not be appropriate (3). Kawasaki disease is a vasculitic syndrome
associated with increased risk for thrombosis (4). Vascular remod-
eling can continue for years (5) and possibly promote graft occlusion.
Such vascular pathology does not exist in AOCA patients.
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